Essbio Past Earnings Performance
Past criteria checks 3/6
Essbio has been growing earnings at an average annual rate of 4.6%, while the Water Utilities industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 8.8% per year. Essbio's return on equity is 7.1%, and it has net margins of 11%.
Key information
4.6%
Earnings growth rate
3.2%
EPS growth rate
| Water Utilities Industry Growth | 4.8% |
| Revenue growth rate | 8.8% |
| Return on equity | 7.1% |
| Net Margin | 11.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Appear Satisfied With Essbio S.A.'s (SNSE:ESSBIO-C) Prospects As Shares Rocket 48%
May 21
We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings
Sep 15Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
May 30A Look At The Intrinsic Value Of Essbio S.A. (SNSE:ESSBIO-C)
Mar 29Should You Be Impressed By Essbio's (SNSE:ESSBIO-C) Returns on Capital?
Mar 09Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden
Feb 15Should Essbio S.A. (SNSE:ESSBIO-C) Focus On Improving This Fundamental Metric?
Jan 04
Has Essbio (SNSE:ESSBIO-C) Got What It Takes To Become A Multi-Bagger?
Dec 08Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
Nov 17Revenue & Expenses Breakdown
How Essbio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 240,932 | 26,610 | 32,941 | 0 |
| 30 Jun 24 | 237,761 | 29,781 | 35,595 | 0 |
| 31 Mar 24 | 236,986 | 32,244 | 34,653 | 0 |
| 31 Dec 23 | 233,768 | 29,684 | 34,820 | 0 |
| 30 Sep 23 | 236,068 | 25,526 | 35,193 | 0 |
| 30 Jun 23 | 232,267 | 15,635 | 34,965 | 0 |
| 31 Mar 23 | 225,304 | 6,926 | 35,608 | 0 |
| 31 Dec 22 | 218,855 | 7,149 | 34,085 | 0 |
| 30 Sep 22 | 209,537 | 6,942 | 33,870 | 0 |
| 30 Jun 22 | 203,861 | 14,469 | 32,316 | 0 |
| 31 Mar 22 | 197,455 | 20,267 | 31,573 | 0 |
| 31 Dec 21 | 188,898 | 18,466 | 31,805 | 0 |
| 30 Sep 21 | 183,492 | 20,347 | 30,637 | 0 |
| 30 Jun 21 | 178,327 | 19,195 | 29,474 | 0 |
| 31 Mar 21 | 175,472 | 20,127 | 27,387 | 0 |
| 31 Dec 20 | 173,777 | 20,786 | 26,213 | 0 |
| 30 Sep 20 | 171,483 | 21,107 | 24,733 | 0 |
| 30 Jun 20 | 170,230 | 21,046 | 24,476 | 0 |
| 31 Mar 20 | 169,935 | 20,094 | 23,995 | 0 |
| 31 Dec 19 | 169,193 | 20,508 | 24,247 | 0 |
| 30 Sep 19 | 168,477 | 21,139 | 24,167 | 0 |
| 30 Jun 19 | 167,463 | 20,702 | 24,405 | 0 |
| 31 Mar 19 | 163,758 | 20,694 | 24,408 | 0 |
| 31 Dec 18 | 159,272 | 19,259 | 23,910 | 0 |
| 30 Sep 18 | 156,185 | 17,720 | 23,984 | 0 |
| 30 Jun 18 | 153,701 | 19,387 | 23,332 | 0 |
| 31 Mar 18 | 151,904 | 22,260 | 23,353 | 0 |
| 31 Dec 17 | 149,564 | 25,132 | 22,961 | 0 |
| 30 Sep 17 | 149,298 | 27,874 | 22,626 | 0 |
| 30 Jun 17 | 148,070 | 26,884 | 22,571 | 0 |
| 31 Mar 17 | 146,712 | 23,866 | 22,421 | 0 |
| 31 Dec 16 | 147,731 | 23,351 | 22,546 | 0 |
| 30 Sep 16 | 141,451 | 27,218 | 21,988 | 0 |
| 30 Jun 16 | 141,813 | 26,833 | 22,045 | 0 |
| 31 Mar 16 | 142,406 | 26,295 | 21,648 | 0 |
| 31 Dec 15 | 140,122 | 25,176 | 21,397 | 0 |
| 30 Sep 15 | 144,233 | 16,276 | 22,503 | 0 |
| 30 Jun 15 | 141,447 | 16,099 | 21,935 | 0 |
| 31 Mar 15 | 137,367 | 13,264 | 21,442 | 0 |
| 31 Dec 14 | 134,834 | 68,059 | 20,918 | 0 |
| 30 Sep 14 | 131,934 | 71,759 | 19,478 | 0 |
| 30 Jun 14 | 130,316 | 71,774 | 19,483 | 0 |
| 31 Mar 14 | 127,730 | 75,169 | 18,702 | 0 |
| 31 Dec 13 | 122,736 | 16,798 | 18,601 | 0 |
Quality Earnings: ESSBIO-C has high quality earnings.
Growing Profit Margin: ESSBIO-C's current net profit margins (11%) are higher than last year (10.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ESSBIO-C's earnings have grown by 4.6% per year over the past 5 years.
Accelerating Growth: ESSBIO-C's earnings growth over the past year (4.2%) is below its 5-year average (4.6% per year).
Earnings vs Industry: ESSBIO-C earnings growth over the past year (4.2%) did not outperform the Water Utilities industry 4.2%.
Return on Equity
High ROE: ESSBIO-C's Return on Equity (7.1%) is considered low.